Skip to main content

Jim Cramer's Advice for Spotting a Healthcare Winner

Publish date:
Video Duration:

Is it time to buy healthcare?

"All year long, we've seen investors swapping out of the stay-at-home stocks in favor of the great reopening stocks. Until now, that meant swapping into one thing -- the cyclicals. But today, that trade ended and investors took a pause on the cyclicals to give some love to technology and healthcare," wrote TheStreet's Scott Rutt in his Mad Money recap.

"These are strange times, Cramer told viewers. The Dow Jones Industrial Average only hits new highs when the economy is booming. And when the economy is strong, so too are interest rates. But on Thursday, we saw interest rates fall, which make technology and healthcare also attractive," he continued.

"The move in healthcare was pronounced, with UnitedHealth Group (UNH) - Get Report soaring 3.8%, GlaxoSmithKline (GSK) - Get Report up 4.3% and Eli Lilly (LLY) - Get Report gaining 1.6%. Even Johnson & Johnson (JNJ) - Get Report was able to eke out gains. The rise in healthcare was met with a similar move in tech, where Cramer favorites Twilio (TWLO) - Get Report and Okta (OKTA) - Get Report rallied 4.8% and 5.5% respectively."

Watch TheStreet Live: Everything Jim Cramer Is Watching Friday.

Curious about what Jim Cramer and his team at Action Alerts PLUS are watching in the markets? Watch Cramer's exclusive members-only Daily Rundown show on Action Alerts PLUS following TheStreet Live.

You can follow Jim Cramer and Katherine Ross on Twitter at @JimCramer and @byKatherineRoss. Read more from Katherine Ross here.

Related Videos